Hanne Schultz Kapel is an experienced professional in the pharmaceutical and biotech industries, currently serving as CMO, CCO, Co-Owner, and Board Member at ParaTech A/S, where responsibilities include designing and managing clinical trials and overseeing medical and regulatory affairs. Additionally, Hanne is a Senior Medical Affairs Scientist Consultant for Pfizer and operates KAPEL Consulting ApS, providing expert advisory services across multiple therapeutic areas. With a strong background in oncology and a history of leadership roles in companies such as OncologyPipeline and Roche, Hanne possesses extensive expertise in commercial management, project management, and marketing. Hanne holds an M.Sc. in Pharmacy from the University of Copenhagen and has completed an executive program in Managing Medical Sales & Marketing.